Trial intelligence / Profile preview

EC-wP vs EP-wP in Young Breast Cancer

NCT01026116Phase 3Completed

Sponsor
Fudan University
Start
Dec 2009
Primary completion
Jan 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of paclitaxel in breast cancer, sponsored by Fudan University. Started Dec 2009; status: completed.

02

Drugs

paclitaxel
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT01026116.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01026116.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call